Hyperbaric Oxygen Therapy: What's FDA-Approved, What's Experimental, and What's Marketing

Key takeaway: HBOT is a legitimate, well-studied medical treatment for 14 specific conditions. It has been used since the 1960s in specialized clinical settings (PMID 37356018). It is not a wellness biohack, and the gap between what's proven and what's marketed is enormous. This guide maps the evidence for every major claim so you can make an informed decision.

Hyperbaric oxygen therapy has 14 FDA-cleared indications. The wellness industry markets it for about 50 more. Here's where the evidence actually is.

I keep seeing HBOT sold alongside infrared saunas, cryotherapy, and IV drips — bundled into "longevity packages" at $300 a pop. And it drives me up the wall, because unlike most of the things on that menu, HBOT actually has a serious evidence base. For specific conditions. Under specific protocols. In specific chambers. The problem is that almost none of what's marketed to wellness consumers matches those conditions, protocols, or chambers.

HBOT has been a specialized branch of medicine since the 1960s, with established protocols in wound care, diving medicine, and emergency toxicology (PMID 37356018). It isn't new. It isn't alternative. And the fact that it's being repackaged as a biohack is a disservice to both the therapy and the people paying out of pocket for it.

So let me do what I do: separate the chemistry from the marketing.

How Hyperbaric Oxygen Therapy Actually Works

The physics here are straightforward, and if you remember anything from high school chemistry, this will click fast.

Henry's Law states that the amount of gas dissolved in a liquid is proportional to the partial pressure of that gas above the liquid. Breathe air at normal atmospheric pressure (1 ATA) and your hemoglobin carries about 97% of the oxygen in your blood. Your plasma — the liquid portion — carries very little. You're already near max on the hemoglobin side. There's not much room to push oxygen delivery higher through normal breathing.

HBOT changes the equation by manipulating both variables: you breathe 100% oxygen (instead of 21% in normal air) inside a pressurized chamber at 1.5 to 3.0 ATA (atmospheres absolute). The result? Oxygen dissolves directly into your plasma at concentrations 10 to 15 times normal. Your plasma becomes an oxygen delivery vehicle independent of hemoglobin.

This matters because plasma reaches tissues that red blood cells can't always access — areas with compromised blood supply, swollen or damaged capillaries, or ischemic tissue where circulation is impaired. The dissolved oxygen diffuses farther, reaching cells that would otherwise be starved.

The therapeutic mechanisms downstream of this hyperoxia include:

• Neovascularization: Stimulating the growth of new blood vessels in damaged tissue
• Fibroblast proliferation: Accelerating collagen synthesis and wound repair
• Immune enhancement: Oxygen-dependent white blood cell killing of bacteria (particularly anaerobes)
• Edema reduction: Vasoconstriction that reduces swelling without reducing oxygen delivery (because dissolved O2 compensates)
• Reduction of pathologic inflammation: Demonstrated in burn treatment models, where HBOT improves tissue hypoxia and reduces inflammatory cascades (PMID 31701218)

None of this is controversial. It's gas physics applied to biology. The controversy starts when people extrapolate from "more oxygen reaches damaged tissue" to "more oxygen fixes everything."

The 14 FDA-Cleared Indications

The FDA has cleared HBOT for exactly 14 conditions. These aren't suggestions — they're the indications for which clinical evidence met the FDA's threshold and for which treatment protocols have been standardized by the Undersea and Hyperbaric Medical Society (UHMS). Here's the full list with my assessment of evidence strength:

Notice what these all have in common: tissue that's either acutely poisoned, critically ischemic, infected with anaerobes, or failing to heal despite standard treatment. HBOT isn't the first-line therapy for any of them except decompression sickness and arterial gas embolism. For everything else, it's an adjunct — used alongside surgery, antibiotics, wound care, or transfusion when those alone aren't enough.

Also notice: depression isn't on this list. Neither is ADHD, autism, athletic recovery, anti-aging, or "brain fog." We'll get to those.

The Wellness Claims: What's Actually Experimental

Here's where it gets murky, and where I need to be precise. "Experimental" doesn't mean "fake." It means the evidence hasn't reached the threshold for FDA clearance or consensus clinical guidelines. Some of these uses have promising preliminary data. Others have essentially nothing beyond theoretical rationale and marketing copy.

Traumatic Brain Injury and PTSD

This is probably the most studied non-FDA-approved indication, largely because the Department of Defense has invested heavily in it. A comprehensive military medicine review examined HBOT for TBI, PTSD, and chronic pain — conditions affecting hundreds of thousands of service members (PMID 33564849). The findings: HBOT shows some signal for mild TBI symptom improvement in certain trials, but the evidence is inconsistent, study designs vary widely, and the therapy is currently NOT FDA-approved for any of these conditions. DoD research is ongoing.

What that means in plain language: the military thinks it's worth studying. That's not the same as "it works." And the fact that active-duty research programs are investigating HBOT for TBI doesn't validate the wellness clinic down the street charging $250/session for "brain optimization."

Long COVID

A handful of small trials have looked at HBOT for persistent post-COVID symptoms — fatigue, cognitive dysfunction, exercise intolerance. Some showed improvements in neurocognitive testing. But the studies are small (typically 30-70 participants), often lack proper sham controls, and don't yet tell us whether HBOT outperforms time, exercise rehabilitation, or placebo. This is legitimately promising early research. It is not evidence sufficient to recommend the treatment.

Anti-Aging and Telomere Lengthening

One small Israeli trial (n=35) made headlines claiming HBOT lengthened telomeres and reduced senescent cells. The study was real. But it was tiny, lacked a control group receiving pressurized room air (a critical methodological gap), and hasn't been independently replicated. Despite this, it launched a thousand Instagram ads. If someone is selling you telomere lengthening via HBOT, they are selling you a single unreplicated study on 35 people.

Cognitive Enhancement and "Brain Health"

The proposed mechanism — increased cerebral oxygen delivery improves neural function — is plausible in theory. In practice, healthy brains already have adequate oxygen delivery. The studies showing cognitive benefit are almost exclusively in populations with brain injury or cerebrovascular disease. Extrapolating to healthy adults seeking a cognitive edge has no meaningful evidence behind it. Zero.

Athletic Recovery and Performance

Athletes love HBOT. The evidence doesn't love them back. Studies on delayed-onset muscle soreness (DOMS), post-exercise recovery time, and sports injury healing have been inconsistent at best. Most positive results come from case reports or uncontrolled studies. The well-designed RCTs generally show minimal to no benefit over standard recovery protocols. Yet this is one of the most commonly marketed wellness applications.

Autism Spectrum Disorder

Multiple studies have examined HBOT for ASD symptoms. The largest RCT (2009, n=62) showed modest improvements in some behavioral measures at 1.3 ATA — but subsequent studies have failed to consistently replicate these results, and systematic reviews have concluded the evidence is insufficient to recommend HBOT for ASD. The FDA has specifically warned consumers about this marketing claim.

Soft-Shell vs Hard-Shell Chambers: The Distinction Most Wellness Centers Don't Explain

This is the section that matters most if you're considering HBOT at a wellness center rather than a hospital or wound care clinic. Because the chamber type determines whether you're even getting a therapeutically relevant dose.

Hard-shell (monoplace or multiplace) chambers are what hospitals use. They're rigid, pressurized vessels — essentially small submarines. They deliver 100% oxygen at pressures of 2.0 to 3.0 ATA. Every FDA-cleared protocol and every major clinical trial used hard-shell chambers at these pressures. This is what the evidence is built on.

Soft-shell (mild or portable) chambers are inflatable, zippered bags that pressurize to a maximum of about 1.3 ATA. Most deliver ambient air (21% oxygen), not 100% oxygen, because delivering pure O2 in a non-rated vessel is a fire hazard. Some use oxygen concentrators that achieve 24-40% oxygen.

The math is unforgiving. At 1.3 ATA with 24% oxygen, you're getting a partial pressure of about 0.31 ATA of O2. At 2.5 ATA with 100% oxygen, you're getting 2.5 ATA of O2. That's roughly an 8x difference in the oxygen dose reaching your plasma. They are not equivalent treatments. They are not even in the same therapeutic category.

Yet many wellness centers use soft-shell chambers and market the same conditions, the same benefits, and the same research that was generated in hard-shell chambers at 2-3x the pressure. This is the single biggest piece of information that gets omitted from wellness HBOT marketing. When a clinic says "hyperbaric oxygen therapy" and charges you $200 per session, ask: what pressure, what oxygen concentration, and what type of chamber? If the answer is 1.3 ATA in a soft-shell, you are not receiving the treatment described in the clinical literature.

Is 1.3 ATA with concentrated oxygen completely useless? Probably not — there may be some marginal benefit for certain conditions. But the evidence base at that pressure is thin, and calling it "HBOT" in the same breath as the treatment that heals diabetic ulcers and treats decompression sickness is misleading at best.

Safety: The Real Risks of HBOT

HBOT is generally safe when administered properly in a clinical setting, but "generally safe" comes with caveats that matter.

Barotrauma

The most common side effect. Pressure changes affect air-filled spaces in your body — sinuses, middle ear, and (rarely) lungs. Middle ear barotrauma occurs in roughly 2-10% of patients and ranges from mild discomfort to tympanic membrane rupture. If you've ever had trouble equalizing on an airplane, HBOT will be worse. Sinus barotrauma is less common but can cause significant pain and nosebleeds.

Oxygen Toxicity Seizures

Breathing 100% oxygen at high pressures for extended periods can cause central nervous system oxygen toxicity, manifesting as seizures. The risk is dose-dependent — higher pressures and longer exposures increase it. At standard clinical protocols (2.0-2.5 ATA for 90 minutes), the seizure rate is approximately 1-3 per 10,000 treatments. Low, but not zero. Seizures during treatment are usually self-limiting once the oxygen is removed, but they're terrifying and disqualifying for further treatment.

Pulmonary Oxygen Toxicity

Extended courses of HBOT (30+ sessions) can cause reversible changes in pulmonary function — decreased vital capacity, chest tightness, cough. This is managed by limiting session duration and including "air breaks" during treatment. It's typically a concern only in long treatment courses.

Fire Risk

Pure oxygen environments are extreme fire hazards. Hard-shell chambers have strict protocols: no electronics, no petroleum-based products, no synthetic fabrics. Violations have caused fatal chamber fires. This is why legitimate HBOT facilities are obsessive about pre-treatment screening and why home use of high-pressure oxygen equipment is genuinely dangerous.

Claustrophobia and Anxiety

Monoplace chambers are tight. Some patients cannot tolerate them. This isn't a medical risk per se, but it's a real barrier to treatment and a common reason for discontinuation. Multiplace chambers (where multiple patients sit in a pressurized room) are better tolerated by claustrophobic patients.

Contraindications

Absolute contraindications include untreated pneumothorax and certain chemotherapy drugs (bleomycin, cisplatin — HBOT can potentiate lung toxicity). Relative contraindications include upper respiratory infections, uncontrolled seizure disorders, severe COPD, and pregnancy (limited safety data).

Cost and Insurance Reality

Here's the financial picture, and it's stark:

For FDA-approved conditions: Insurance may cover HBOT when prescribed by a physician for an approved indication. Medicare covers it for specific wound types (diabetic ulcers, delayed radiation injury) with documentation requirements. Coverage varies by plan, and prior authorization is almost always required. Hospital-based HBOT typically runs $300-$1,000 per session before insurance — a 40-session wound care protocol can exceed $20,000.

For everything else: You're paying out of pocket. Wellness centers charge $150-$300 per session. Most recommend packages of 10-40 sessions. That's $1,500-$12,000 for a treatment course with no insurance reimbursement and, for most marketed conditions, no strong evidence of efficacy. Some centers offer monthly memberships at $500-$1,500/month for regular sessions.

Before spending that money, ask yourself: Is this for an FDA-cleared indication? Is it a hard-shell chamber at therapeutic pressure? Is there a physician supervising the treatment? Is there published evidence at this specific protocol? If any answer is "no," you should understand exactly what you're buying and why.

Evidence Tier Assessment: Every Major Condition

I've organized every condition I could find marketed in connection with HBOT into evidence tiers. This is my assessment based on the current literature — not a clinical recommendation, but a framework for evaluating claims.

If the condition you're considering falls in the bottom two tiers, you're not necessarily wrong to try HBOT — but you should be fully informed that the evidence isn't there yet, and your expectations should be calibrated accordingly. And you should be especially skeptical if a provider presents weak or absent evidence as settled science.

Frequently Asked Questions

How many HBOT sessions does it take to see results?

It depends entirely on the condition. Emergency indications (decompression sickness, CO poisoning) often require 1-5 sessions. Chronic wounds and radiation injuries typically require 20-40 sessions over 4-8 weeks. Wellness centers recommending 40+ sessions for non-FDA-approved conditions are extrapolating from wound care protocols without evidence that the same dosing applies.

Can I do HBOT at home with a portable chamber?

Soft-shell home chambers exist and are sold for $5,000-$20,000+. They max out at 1.3 ATA with ambient or mildly concentrated oxygen. This is a fraction of the therapeutic dose used in clinical HBOT. You should also know that the FDA has issued warnings about misleading claims for home HBOT devices. If you buy one, understand that you're getting mild pressurization, not the treatment studied in clinical trials. And never, under any circumstances, use supplemental oxygen in a non-rated chamber without professional supervision — the fire risk is real and fatal.

Is HBOT painful?

Not painful, but it can be uncomfortable. Ear and sinus pressure during compression is the main issue — similar to descending in an airplane but more intense. You'll need to equalize frequently. Some patients experience temporary vision changes (myopic shift) during long treatment courses, which typically reverses after treatment ends. Oxygen toxicity symptoms, if they occur, start with twitching around the mouth and face.

What should I look for in an HBOT provider?

At minimum: a hard-shell chamber, treatment administered at 2.0+ ATA with 100% oxygen, physician oversight (ideally a doctor certified in undersea and hyperbaric medicine), and a facility accredited by UHMS. If the provider can't tell you the exact pressure, oxygen concentration, and treatment protocol they use — or if they don't have a physician involved — find a different provider. The BestDosage directory lists HBOT centers with their chamber types and protocols where available.

Are certain people more at risk from HBOT?

Yes. People with a history of pneumothorax, ear surgery, severe COPD, or seizure disorders face higher risks. Anyone taking bleomycin or certain other chemotherapy drugs should not undergo HBOT. Pregnant women are generally excluded from treatment due to insufficient safety data. People with upper respiratory infections should postpone treatment (equalization becomes impossible and barotrauma risk spikes). A proper HBOT facility will screen for all of these before your first session.

The Bottom Line

HBOT is real medicine with real applications. It has been saving lives and limbs since the 1960s. The 14 FDA-cleared indications are backed by decades of clinical evidence in hard-shell chambers at therapeutic pressures.

What HBOT is not: a general wellness treatment, a biohacking shortcut, or a substitute for evidence you wish existed. If you're considering it for a non-FDA-approved condition, go in with eyes open. Know the chamber type. Know the pressure. Know the evidence tier. And be deeply skeptical of any provider who conflates the legitimate clinical applications of HBOT with the speculative wellness claims built on unreplicated studies and marketing momentum.

The chemistry works. The question is always whether the chemistry applies to your specific situation — and whether the specific protocol being offered matches the evidence.

Looking for HBOT providers near you? Find hyperbaric oxygen therapy centers in the BestDosage directory — filtered by chamber type, provider credentials, and patient reviews.